| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 720,730 | 891,853 | 593,063 | 1,278,048 | | Cost of Revenue | 770,321 | 1,010,537 | 568,919 | 1,469,194 | | | Gross Profit | (49,591) | (118,684) | 24,144 | (191,146) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,053 | (70,938) | 129,208 | 31,299 | | Non Recurring |
-
|
-
|
-
| (5,600) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (77,644) | (47,746) | (105,064) | (216,845) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (51,697) | (22,522) | (47,834) |
-
| | Earnings Before Interest And Taxes | (168,865) | (123,638) | (154,081) | (94,950) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (168,865) | (123,638) | (154,081) | (94,950) | | Income Tax Expense | 2,740 | 1,547 | 1,848 | 716,039 | | Minority Interest | 2,779 | 6,520 | 1,734 | (4,903) | | | | Net Income From Continuing Ops | (171,605) | (125,185) | (155,929) | (810,989) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (171,605) | (125,185) | (155,929) | (810,989) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($171,605) | ($125,185) | ($155,929) | ($810,989) |
|
2.03% Nasdaq 
Income Statement
